Applied Therapeutics, Inc. Operating Lease Right-of-Use Assets
Applied Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $2.47 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Assets
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-11-13
- 2025-09-30: Operating Lease, Right-of-Use Asset $2.47M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $2.58M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $2.69M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $2.79M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $2.47M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.58M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.69M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.79M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $1.96M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $206.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $328.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $447.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $510.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $628.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $743.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $857.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $970.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.08M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.19M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.30M 10-K · filed 2023-03-23 |
| 2021-09-30 | $1.40M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.51M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.61M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.71M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.75M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.85M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $1.94M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.04M 10-K · filed 2021-03-18 |